Quantcast

Latest Novartis Stories

2014-09-19 00:21:26

BASEL, Switzerland, Sept. 19, 2014 /PRNewswire/ -- -- Global network of over 3,500 farms established to measure productivity -- First independently-audited data to be published in March 2015 -- Projects underway in all regions; partnerships agreed and expanded Syngenta today provided an update on the progress of The Good Growth Plan one year after its launch in September 2013. The Plan comprises six measurable commitments for the year 2020 to help address the global food...

2014-09-12 16:24:47

WASHINGTON, Sept. 12, 2014 /PRNewswire/ -- Syngenta today responded to the lawsuit filed against Syngenta Seeds, Inc. in Louisiana state court by Cargill. Syngenta believes that the lawsuit is without merit and strongly upholds the right of growers to have access to approved new technologies that can increase both their productivity and their profitability. The Agrisure Viptera(®) trait (MIR162) was approved for cultivation in the U.S. in 2010. Syngenta commercialized the trait...

2014-09-12 16:23:36

DUBLIN, Sept. 12, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Diclofenac Industry Report 2014" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The Global Diclofenac Industry Report 2014 is a professional and in-depth study on the current state of the global diclofenac industry . The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The...

2014-09-12 12:22:13

- "Right to Grow" program offers U.S. farmers corn rootworm control and a stewardship premium for Agrisure Duracade corn planted in 2015 MINNETONKA, Minn., Sept. 12, 2014 /PRNewswire/ -- Syngenta announced today that it has renewed and enhanced its program with Gavilon Grain, LLC, to provide grain marketing opportunities for U.S. farmers who plant Agrisure Duracade(TM) in 2015. Agrisure Duracade is Syngenta's cutting-edge corn rootworm (CRW) control technology approved in the U.S....

2014-09-11 20:21:43

Clinical oncology expert joins as company advances late-stage clinical programs BOULDER, Colo., Sept. 11, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients with cancer, today announced the appointment of Victor Sandor, M.D., as Chief Medical Officer. Dr. Sandor will be responsible for leading clinical, medical and regulatory strategy and...

2014-09-10 23:02:27

ReportsnReports.com adds “2014 Market Research Report on Global Diclofenac Industry” and “2014 Deep Research Report on Global and China DL-Mandelic Acid Industry” report to its store. Dallas, TX (PRWEB) September 10, 2014 2014 Market Research Report on Global Diclofenac Industry is a professional and in-depth study on the current state of the Diclofenac industry in Global and China. The report provides a basic overview of the industry, including definitions, applications and...

2014-09-10 12:28:52

-Dr. Cagnoni Joins Non-Profit Organization Focused on Fostering Innovation and Collaboration to Strengthen the Bay Area BioEconomy- SAN FRANCISCO, Sept. 10, 2014 /PRNewswire/ -- The Bay Area BioEconomy Initiative (BAB) today announced that it has named Pablo J. Cagnoni, M.D., President of Onyx Pharmaceuticals, Inc., to its Steering Committee. Onyx, an Amgen subsidiary, is engaged in the development and commercialization of innovative therapies to improve the lives of people with...

2014-09-09 08:33:27

DUBLIN, Sept. 9, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Active Pharmaceutical Ingredients Market - Forecast to 2020" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Active Pharmaceutical Ingredients (API) are active substances used in pharmaceutical drug product intended to achieve pharmacological activity or induce beneficial health effects by having direct effect on diagnosis, prevention or treatment of disease in...

2014-09-09 08:32:26

DUBLIN, Sept. 9, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Human Vaccine Technologies Market" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Immunization is one of the highest impact and most cost effective methods of preventing infectious diseases, particularly in low and middle income countries with minimal healthcare facilities in remote locations. Many vaccines technologies that could aid improved safety, efficacy and...

2014-09-08 16:25:38

ST. PAUL, Minn., Sept. 8, 2014 /PRNewswire/ -- Prime Therapeutics, LLC (Prime) has submitted comments to the U.S. Food and Drug Administration (FDA) in support of two citizen petitions on the naming of biosimilar drugs. Biosimilars are medically equivalent versions of biologics, used to treat complex illnesses such as cancer. The citizen petitions were filed in 2013 by the Generic Pharmaceutical Association (GPhA) and Novartis. The petitions urged the FDA to adopt a naming system...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related